Copyright: ©Author(s) 2026.
World J Gastrointest Pharmacol Ther. Sep 5, 2026; 17(3): 120771
Published online Sep 5, 2026. doi: 10.4292/wjgpt.120771
Published online Sep 5, 2026. doi: 10.4292/wjgpt.120771
Figure 2 Colonoscopy findings in case 2 on maintenance therapy with ustekinumab every 8 weeks and tofacitinib 5 mg twice daily (mildly symptomatic).
Improvement, but still presenting ulcerative colitis with patchy areas of stricture, friability and ulcers, Mayo endoscopic score 2. A: Descending colon; B: Sigmoid colon.
- Citation: Soldera J, Pertile MAS, Carobin LN, Brambilla DJF, Brambilla E. Beyond class switching in multi-refractory inflammatory bowel disease: Nine case reports and review of literature. World J Gastrointest Pharmacol Ther 2026; 17(3): 120771
- URL: https://www.wjgnet.com/2150-5349/full/v17/i3/120771.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.120771